mamacrowd-logo
InvestRaiseFund&CrowdGuideNews
LoginSign up
Pharmercure
Pharmercure | Mamacrowd

Pharmercure

Marketplace

Pharmercure is the delivery platform for all products that can be purchased in pharmacies, including prescription drugs.

  • 5x growth and €1M+ Gross Merchandise Value in 2020

  • 8M+ people covered by the service, active in 15 provinces

  • €1M+ in fundraising over three years, from public and private investors

  • Proprietary GDPR-compliant technologies on data and processes

TAX Bonus

Innov STARTUP

SIM

    Project
    Team and Shareholders
    Market and Target
    Business Model
    Financial projections
    Use of funds
    Rewards for Investors
immagine copertina
The content of this page has been translated automatically

Project

Pharmercure is an innovative startup from Turin, launched in 2018 by a team of young talents, included by Forbes in the 2021 list of the 100 Under-30 Leaders of the Future.

 

It is one of the very few realities in Europe able to bring individual pharmacies online, enhancing their professionalism and expertise, and to offer users amarketplace experience for any product that can be purchased in a pharmacy, including prescription drugs.

 

A digital and physical connection bridge between pharmacists and their customers, thanks to a fast, structured and high quality"door-to-door" delivery service, using selected and labour-protected couriers.

 

Pharmercure brings the products of their favourite pharmacies to citizens' homes, together with the professionalism of their trusted pharmacists.

Customer needs

The service is aimed, on the one hand, at all those customers who need medication, or even just professional advice, but are unable to go to the pharmacy due to mobility problems, lack of available time or simple inconvenience.

 

On the other hand, it supports pharmacy owners by placing the professionalism of the pharmacist at the centre of the process, to make it evolve thanks to digital technologies, but defending it from the logic and possible threats of large-scale distribution and destructive competition.

 

Technology

In a market where it is forbidden to sell prescription drugs online, Pharmercure has changed the paradigm with its technological platform , connecting pharmacies and users and enhancing the role of the pharmacist, making him central in the whole process.

 

A complex study of regulations, the application of proprietary technologies and the construction of solid operations allow Pharmercure to manage the online booking of any product that can be purchased in a pharmacy, including prescription drugs, and the related delivery.

 

Customer and traction

Over the past three years, Pharmercure has experienced significant growth, raising over €1 million in funding from institutional, private and public capital.

In 2020 it has quintupled all the main business metrics, exceeding 30,000 deliveries and reaching 1 million Euros in Gross Merchandise Value.

 

The service is currently active in 15 Italian provinces with 90 pharmacies on the territory, for a total coverage of over 8 million people, boasting partnerships with major players in the sector.

 

On the Pharmercure campaign is active the Massive Rubrication service. The service is free for the Investor as the costs are borne by Pharmercure.

20210808140827_3862a423_Progetto%201

Want to find out more about this project?

Register or log in, if you already have an account, to view all information in detail

Sign up
Login

Pharmercure

Marketplace

Closed 11/10/2021
funded

Total funding

1.132.033 €

Goal min 1,10Mln €

Goal max 1,50Mln €

Professional Investor

Professional Inv.


71 investors

103% Goal min


Min order

996,96 €


Pre-Money

6,39Mln €

The information on the offer is not subject to approval by Consob. The Offering company is solely responsible for the completeness and truthfulness of the data and information provided by the latter. The investor's attention is also drawn to the fact that the investment, even indirect, through OICR or companies that invest mainly in financial instruments issued by innovative startups and SMEs is illiquid and characterised by a very high risk.
mamacrowd-logo

About us

Who we are

Press

Power User program

News

Carrers

Company informations

Real Estate Statistics

Crowdfunding services

Guide for the investor

Crowdfunding services

Investment costs

Risk warning

Alternative allowance regime

Tax benefits

Arbitrator for financial disputes

Dematerialized system

Trust company header service

Support

How to start

FAQ

Contacts

Terms & Conditions

Power User Terms & Conditions

Privacy Policy

Cookies Policy

Recovery Policy

Conflicts of Interest Policy

Handle Cookies

Warnings pursuant to art. 19 para. 2
the crowdfunding services provided by Mamacrowd do not fall under the deposit guarantee scheme established in accordance with Directive 2014/49/EU; the securities and instruments eligible for crowdfunding that can be acquired through this crowdfunding platform do not fall under the investor compensation scheme established in accordance with Directive 97/9/EC.

 

© 2025 Mamacrowd Srl a company of Azimut Group - VAT number IT07464370969 - Via Timavo 34, 20124 MI - SC € 95.417,54 fully paid up - Crowdfunding service provider authorised by resolution No. 22876 of 08/11/2023

  • Italiano

  • English

    Invest
      Invest in Startup/PMI and real estate projects
      Investor guide

    Raise
      Candidate a project

  • Italiano

  • English

Let us get to know you better

Mamacrowd and partners operate globally and can, upon acquiring your consent through the "Accept all", "Accept only necessary" or "Set preferences" commands, use cookies for statistical, advertising and also profiling purposes, own or third-party, to modulate the provision of the service in a personalized way and in line with your preferences.
In case of refusal we will only use the necessary cookies. For more information, read our Cookies Policy

Set preferences
Accept only necessary